Spatial map of microglial diversity beyond proteopathy

1. Prinz, M., Jung, S. & Priller, J. Microglia biology: one century of evolving concepts. Cell 179, 292–311 (2019). A comprehensive review charting the historical and conceptual development of microglial research.

   CAS  PubMed  Google Scholar 

2. Keren-Shaul, H. et al. A unique microglia type associated with restricting development of Alzheimer’s disease. Cell 169, 1276–1290.e17 (2017). Seminal primary study that first defined disease-associated microglia and highlighted subtype heterogeneity in Alzheimer’s disease.

   CAS  PubMed  Google Scholar 

3. Vijayaragavan, K. et al. Single-cell spatial proteomic imaging for human neuropathology. Acta Neuropathol. Commun. 10, 158 (2022). Peer-reviewed protocol and dataset describing the MIBI workflow for high-plex in situ proteomics of human brain tissue.

   PubMed  PubMed Central  Google Scholar 

4. Mrdjen, D. et al. High-dimensional single-cell mapping of central nervous system immune cells reveals distinct myeloid subsets in health, aging and disease. Immunity 48, 380–395.e6 (2018). This paper introduced mass cytometry-based single-cell proteomics to profile immune diversity in the central nervous system, inspiring the continuum approach.

   CAS  PubMed  Google Scholar 

5. Corces, M. R. et al. Single-cell epigenomic analyses implicate causal variants at inherited risk loci for Alzheimer’s and Parkinson’s diseases. Nat. Genet. 52, 1158–1168 (2020). This paper provides the single-nucleus ATAC-seq dataset and analytical framework we used to construct the epigenetic continuum.

   CAS  PubMed  PubMed Central  Google Scholar 

Download references

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

This is a summary of: Mrdjen, D. et al. Spatial proteomics reveals Alzheimer’s disease-specific human microglial states. Nat. Immunol. https://doi.org/10.1038/s41590-025-02203-w (2025).